Lara Sucheston-Campbell
Directeur Technique/Scientifique/R&D chez IMMUNOVIA AB
Profil
Lara E.
Sucheston-Campbell is currently the Global Director-Clinical Development at Roche Molecular Systems, Inc. and will be the Head-Clinical & Medical Affairs at Immunovia AB starting in 2023.
She holds a doctorate degree from Case Western Reserve University and a graduate degree from The Ohio State University.
Postes actifs de Lara Sucheston-Campbell
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOVIA AB | Directeur Technique/Scientifique/R&D | 01/02/2023 |
Roche Molecular Systems, Inc.
 Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Corporate Officer/Principal | - |
Formation de Lara Sucheston-Campbell
| Case Western Reserve University | Doctorate Degree |
| The Ohio State University | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IMMUNOVIA AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Health Services |
